- Helps manage blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications.
- Promotes weight loss in overweight individuals with type 2 diabetes.
- Improves insulin sensitivity and glucose metabolism.
- Can be used in combination with other antidiabetic medications.
- May lower the risk of cardiovascular events in diabetic patients.
- Facilitates better glycemic control when diet and exercise are insufficient.
Dapabiso 10/1.25 mg Tablet - Strip of 10
Compositions : Dapagliflozin 10mg + Bisoprolol 1.25mg
MRP :
MRP :
Out of stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Zydus Healthcare Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Dapabiso 10/1.25 mg Tablet is a pharmaceutical product designed to assist in the management of specific health conditions. This medication combines two active ingredients: Dapagliflozin and Metformin. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing glucose reabsorption in the kidneys, thereby promoting its excretion through urine. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity and decreases hepatic glucose production. Together, these components create a synergistic effect that helps regulate blood sugar levels in individuals with type 2 diabetes. The primary therapeutic purpose of Dapabiso 10/1.25 mg Tablet is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone are insufficient. This medication is often prescribed as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels. It is crucial for patients to understand the importance of adhering to their prescribed regimen to achieve optimal results and minimize the risk of complications associated with diabetes. Dapabiso 10/1.25 mg Tablet is typically taken orally, making it convenient for daily use. Patients should consult their healthcare provider for personalized advice regarding the use of this medication, including potential benefits and any necessary precautions.
Product Details
- Dapagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased urinary glucose excretion leads to lower blood sugar levels.
- Metformin enhances insulin sensitivity in muscle and fat tissues.
- Decreases hepatic glucose production, further aiding in blood sugar control.
- The combination of both drugs provides a dual mechanism for effective glycemic management.
- Take Dapabiso 10/1.25 mg Tablet orally with or without food.
- The typical starting dose is one tablet once daily, as directed by your healthcare provider.
- Dosage may be adjusted based on individual response and tolerability.
- It is essential to take the medication at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking the medication even if you feel well; do not stop without consulting your doctor.
- Regular monitoring of blood glucose levels is recommended to assess treatment efficacy.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your progress.
- Avoid excessive consumption of sugary foods and beverages.
- Stay hydrated by drinking plenty of water throughout the day.
- Manage stress through relaxation techniques such as yoga or meditation.
Safety Advice
Side Effects
- Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort.
- Some patients may experience urinary tract infections or genital fungal infections.
- Serious side effects may include dehydration, kidney problems, or severe allergic reactions.
- If you notice symptoms like extreme thirst, frequent urination, or fatigue, seek medical attention promptly.
- Contact your healthcare provider if you experience any unusual or severe side effects during treatment.
Precautions and Warnings
- Dapabiso 10/1.25 mg Tablet is contraindicated in patients with severe renal impairment or end-stage renal disease.
- Use caution if you have a history of bladder cancer or urinary tract infections.
- Monitor kidney function regularly while on this medication.
- Avoid alcohol consumption as it may increase the risk of dehydration and affect blood sugar levels.
- Consult your doctor before using this medication if you are pregnant or breastfeeding.
- Driving or operating heavy machinery may be affected; assess your response to the medication first.
FAQs
Dapabiso 10/1.25 mg Tablet may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Always consult your healthcare provider.
2. What should I do if I miss a dose?
If you miss a dose of Dapabiso 10/1.25 mg Tablet, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and resume your regular schedule.
3. Can I take Dapabiso 10/1.25 mg Tablet with other medications?
Dapabiso 10/1.25 mg Tablet may interact with other medications. Inform your healthcare provider about all medications you are taking.
4. How should I store Dapabiso 10/1.25 mg Tablet?
Store Dapabiso 10/1.25 mg Tablet at room temperature, away from moisture and heat. Keep it out of reach of children.
5. What are the common side effects?
Common side effects may include nausea, diarrhea, and urinary tract infections. Contact your doctor if you experience severe side effects.
6. Can I drink alcohol while taking Dapabiso 10/1.25 mg Tablet?
It's advisable to limit alcohol consumption while taking Dapabiso 10/1.25 mg Tablet, as it can affect blood sugar levels.
7. How long will I need to take this medication?
The duration of treatment with Dapabiso 10/1.25 mg Tablet will depend on your individual health needs and response to therapy.
Instructions
Directions for Use
Storage and Disposal
More Information
| SKU | 117997 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Zydus Healthcare Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Dapabiso 10/1.25 mg Tablet is a pharmaceutical product designed to assist in the management of specific health conditions. This medication combines two active ingredients: Dapagliflozin and Metformin. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing glucose reabsorption in the kidneys, thereby promoting its excretion through urine. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity and decreases hepatic glucose production. Together, these components create a synergistic effect that helps regulate blood sugar levels in individuals with type 2 diabetes. The primary therapeutic purpose of Dapabiso 10/1.25 mg Tablet is to improve glycemic control in adults with type 2 diabetes, particularly when diet and exercise alone are insufficient. This medication is often prescribed as part of a comprehensive treatment plan that includes lifestyle modifications and regular monitoring of blood glucose levels. It is crucial for patients to understand the importance of adhering to their prescribed regimen to achieve optimal results and minimize the risk of complications associated with diabetes. Dapabiso 10/1.25 mg Tablet is typically taken orally, making it convenient for daily use. Patients should consult their healthcare provider for personalized advice regarding the use of this medication, including potential benefits and any necessary precautions.
- Helps manage blood sugar levels in adults with type 2 diabetes.
- Reduces the risk of diabetes-related complications.
- Promotes weight loss in overweight individuals with type 2 diabetes.
- Improves insulin sensitivity and glucose metabolism.
- Can be used in combination with other antidiabetic medications.
- May lower the risk of cardiovascular events in diabetic patients.
- Facilitates better glycemic control when diet and exercise are insufficient.
- Dapagliflozin inhibits SGLT2, reducing glucose reabsorption in the kidneys.
- Increased urinary glucose excretion leads to lower blood sugar levels.
- Metformin enhances insulin sensitivity in muscle and fat tissues.
- Decreases hepatic glucose production, further aiding in blood sugar control.
- The combination of both drugs provides a dual mechanism for effective glycemic management.
- Take Dapabiso 10/1.25 mg Tablet orally with or without food.
- The typical starting dose is one tablet once daily, as directed by your healthcare provider.
- Dosage may be adjusted based on individual response and tolerability.
- It is essential to take the medication at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole with water.
- Continue taking the medication even if you feel well; do not stop without consulting your doctor.
- Regular monitoring of blood glucose levels is recommended to assess treatment efficacy.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your progress.
- Avoid excessive consumption of sugary foods and beverages.
- Stay hydrated by drinking plenty of water throughout the day.
- Manage stress through relaxation techniques such as yoga or meditation.
Side Effects
- Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort.
- Some patients may experience urinary tract infections or genital fungal infections.
- Serious side effects may include dehydration, kidney problems, or severe allergic reactions.
- If you notice symptoms like extreme thirst, frequent urination, or fatigue, seek medical attention promptly.
- Contact your healthcare provider if you experience any unusual or severe side effects during treatment.
Precautions and Warnings
- Dapabiso 10/1.25 mg Tablet is contraindicated in patients with severe renal impairment or end-stage renal disease.
- Use caution if you have a history of bladder cancer or urinary tract infections.
- Monitor kidney function regularly while on this medication.
- Avoid alcohol consumption as it may increase the risk of dehydration and affect blood sugar levels.
- Consult your doctor before using this medication if you are pregnant or breastfeeding.
- Driving or operating heavy machinery may be affected; assess your response to the medication first.
Dapabiso 10/1.25 mg Tablet may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Always consult your healthcare provider.
2. What should I do if I miss a dose?
If you miss a dose of Dapabiso 10/1.25 mg Tablet, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and resume your regular schedule.
3. Can I take Dapabiso 10/1.25 mg Tablet with other medications?
Dapabiso 10/1.25 mg Tablet may interact with other medications. Inform your healthcare provider about all medications you are taking.
4. How should I store Dapabiso 10/1.25 mg Tablet?
Store Dapabiso 10/1.25 mg Tablet at room temperature, away from moisture and heat. Keep it out of reach of children.
5. What are the common side effects?
Common side effects may include nausea, diarrhea, and urinary tract infections. Contact your doctor if you experience severe side effects.
6. Can I drink alcohol while taking Dapabiso 10/1.25 mg Tablet?
It's advisable to limit alcohol consumption while taking Dapabiso 10/1.25 mg Tablet, as it can affect blood sugar levels.
7. How long will I need to take this medication?
The duration of treatment with Dapabiso 10/1.25 mg Tablet will depend on your individual health needs and response to therapy.
Directions for Use
Storage and Disposal
| SKU | 117997 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Zydus Healthcare Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account